Literature DB >> 8797674

Prevention of transneuronal degeneration of neurons in the substantia nigra reticulata by ablation of the subthalamic nucleus.

M Saji1, A D Blau, B T Volpe.   

Abstract

Transneuronal degeneration (TND) of neurons in the substantia nigra reticulata (SNR) occurs after initial ischemic or neurotoxin damage to the striatum. The mechanism is incompletely understood. In rats ibotenic acid (IBO) lesion of the caudate nucleus (CN) and the globus pallidus (GP) caused, 3 weeks later, a 47% loss of neurons (P < 0.001) in the SNR. Rats with IBO lesion confined to either the CN or the GP had SNR neuron numbers comparable to control. The volume of the SNR was decreased, as expected, in all groups with striatal lesions. To test whether the subthalamic nucleus (STN) played a role in the demise of SNR neurons, the STN was lesioned 1 week before animals were exposed to CN and GP injury. STN ablation prevented the expected SNR neuron loss. Based on the current information about basal ganglia anatomy, an imbalance between GABAergic and glutamatergic afferents may have caused TND in the SNR. These results suggest that the potential for the release of intrinsic excitotoxicity exists within certain anatomic networks.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797674     DOI: 10.1006/exnr.1996.0145

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  3 in total

1.  The putative neuroprotective role of dopamine agonists in Parkinson's disease.

Authors:  F Grandas
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

2.  Metabotropic glutamate agonist-induced rotation: a pharmacological, FOS immunohistochemical, and [14C]-2-deoxyglucose autoradiographic study.

Authors:  J A Kearney; K A Frey; R L Albin
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

3.  Tyrosine hydroxylase expression in primary cultures of olfactory bulb: role of L-type calcium channels.

Authors:  E Cigola; B T Volpe; J W Lee; L Franzen; H Baker
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.